John Ormiston is an interventional cardiologist with the Auckland Heart Group who works at Mercy Angiography, Auckland City Hospital, and the North Shore Hospital. He is the Medical Director of Mercy Angiography and is a past president of the Asia Pacific Society for Interventional Cardiology. He is an Associate Professor in Medicine with the University of Auckland School of Medicine and an Honorary Fellow of the Royal College of Physicians (London). He is a member of the Interventional Scientific Council of the American College of Cardiology. His specialist registration is in medicine and radiology.
He is New Zealand’s most experienced interventional cardiologist and has introduced many new technologies and techniques to New Zealand. He was principal investigator of the Absorb Trial and performed the world’s first implantation of a fully bioabsorbable drug-eluting stent. He also implanted the first CoreValve percutaneous aortic valve in the Asia Pacific Region. He and his team plan to introduce the MitraClip technology for percutaneous treatment of mitral regurgitation to New Zealand this year. His research interests include bench testing of stents, stent coatings and other new devices and techniques. His bench testing is world renowned. In addition he has worldwide reputation for clinical trialing of new devices, he is an advisor to a number of interventional cardiology device manufactures. He has published extensively and is a faculty member of the world’s major interventional cardiology meetings.
| Percutaneous Valve Transplants | |||
| Sunday, 13 June 2010 | Start 9:25am | Duration: 25mins | Plenary Room |